Skip to main content
. 2019 Mar 29;22(2):336–340. doi: 10.4048/jbc.2019.22.e17

Figure 2. Magnetic resonance imaging and microscopic findings after neoadjuvant chemotherapy with trastuzumab and pertuzumab. (A) T2-weighted imaging shows a mass showing cystic change. (B) Surgical specimen reveals only mucin pools with no viable tumor cells (hematoxylin and eosin, magnification × 200).

Figure 2